SCHEMBL22145208

SCHEMBL22145208

COc1cccc(-n2c3ccccc3c3c4ccccc4c4c(c32)C=CC(c2ccccc2)(c2ccccc2)O4)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 1/20 0.34
GSK3B P49841 1/20 0.34
USP2 O75604 1/20 0.33
EDNRA P25101 1/20 0.33
POLB P06746 1/20 0.32
NPY1R P25929 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
KDM4E B2RXH2 2/20 0.32
RPS6KB1 P23443 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22145207 0.95 KDM4E (0.33) SMN1; SMN2MAPTGSK3BEDNRAL3MBTL1
SCHEMBL22145204 0.92 L3MBTL1 (0.31) EDNRAL3MBTL1KDM4ERXFP1MEN1
SCHEMBL22145205 0.90 EDNRA (0.34) SMN1; SMN2MAPTEDNRANPY1RL3MBTL1
SCHEMBL22145135 0.90 EDNRA (0.36) SMN1; SMN2MAPTEDNRAKDM4EMEN1
SCHEMBL22145250 0.90 KDM4E (0.36) SMN1; SMN2MAPTEDNRAL3MBTL1KDM4E
SCHEMBL22145137 0.88 L3MBTL1 (0.37) MAPTPOLBL3MBTL1KDM4EMEN1
SCHEMBL22145201 0.87 MAPT (0.36) SMN1; SMN2MAPTEDNRAKDM4EMEN1
SCHEMBL22145191 0.86 PPARG (0.32)
SCHEMBL22145198 0.85 NOTUM (0.32)
SCHEMBL23919144 0.84 KDM4E (0.35) SMN1; SMN2MAPTEDNRAPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898636-B9 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-11-08 EP disclosed
EP-3898636-B1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL LTD (IE) 2023-08-30 EP disclosed
US-20220056039-A1 Indolonaphthopyrans TRANSITIONS OPTICAL, LTD. (IE) 2022-02-24 US disclosed
WO-2020126032-A1 INDOLONAPHTHOPYRANS TRANSITIONS OPTICAL, LTD. (IE) 2020-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220056039-A1 Indolonaphthopyrans TPH1, TPH2, IDO1 SMN1; SMN2 4029/4885MAPT 1575/4885GSK3B 404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.